Johnson & Johnson (JNJ) Return on Invested Capital (2009 - 2026)
Johnson & Johnson (JNJ) posted Return on Invested Capital of 0.0% for Q1 2026, down 3.02% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.
Johnson & Johnson (JNJ) Return on Invested Capital (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital fell to 0.0% in Q1 2026 per JNJ's latest filing, from 0.0% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.0% in Q3 2024, with the low at 0.0% in Q1 2025.
- Average Return on Invested Capital over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
- The widest YoY moves for Return on Invested Capital: up 0 bps in 2022, down 0 bps in 2022.
- Johnson & Johnson's Return on Invested Capital stood at 0.0% in 2022, then soared by 73 bps to 0.0% in 2023, then plunged by 47 bps to 0.0% in 2024, then surged by 59 bps to 0.0% in 2025, then fell by 3 bps to 0.0% in 2026.
- Business Quant data shows JNJ's Return on Invested Capital at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.00% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.00% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.00% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.00% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 0.00% |
| Dec 28, 2025 | 0.00% |
| Sep 28, 2025 | 0.00% |
| Jun 29, 2025 | 0.00% |
| Mar 30, 2025 | 0.00% |
| Dec 29, 2024 | 0.00% |
| Sep 29, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Oct 1, 2023 | 0.00% |
| Jul 2, 2023 | 0.00% |
| Apr 2, 2023 | 0.00% |
| Jan 1, 2023 | 0.00% |
| Oct 2, 2022 | 0.00% |
| Jul 3, 2022 | 0.00% |
| Apr 3, 2022 | 0.00% |
| Oct 3, 2021 | 0.00% |
| Jul 4, 2021 | 0.00% |
| Apr 4, 2021 | 0.00% |